Long-term outcomes with tepotinib for clinically relevant subgroups of patients (pts) with MET exon 14 (METex14) skipping NSCLC in the VISION study: A ≥3-year follow-up
Griesinger, F.;
Ferrara, R.;
Felip, E.;
Smit, E. F.;
Veillon, R.;
외 15명
Citations
WEB OF SCIENCE
0
제목
Long-term outcomes with tepotinib for clinically relevant subgroups of patients (pts) with MET exon 14 (METex14) skipping NSCLC in the VISION study: A ≥3-year follow-up
저자
Griesinger, F.; Ferrara, R.; Felip, E.; Smit, E. F.; Veillon, R.; Le, X.; Mazieres, J.; Cortot, A. B.; Raskin, J.; Thomas, M.; Reinmuth, N.; Yang, J. C-H.; Ahn, M-J.; Zhao, J.; Sakai, H.; Viteri, S.; Wu, Y-L.; Bruns, R.; Johne, A.; Paik, P. K.